Hjärta & Kärl, Hemostas- och Fibrinolys, Hypertension 01-09

 

Bergstrom E, Boman K, Dahlqvist R, Birgander LS. [Do better next time]. Lakartidningen. 2009 Feb 18-24;106(8):527.

 

Bergstrom E, Boman K, Dahlqvist R, Birgander SL. [Criticism against a prioritization project in Vasterbotten. Serious prioritization work requires knowledge and open ethical principles]. Lakartidningen. 2009 Jan 14-20;106(3):126-7.

 

Almroth H, Hoglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. Eur Heart J. 2009 Apr;30(7):827-33.

Andersson J, Jansson JH, Hellsten G, Nilsson TK, Hallmans G, Boman K. Effects of heavy endurance physical exercise on inflammatory markers in non-athletes. Atherosclerosis. 2009 Oct 29.

Hagnelius NO, Boman K, Nilsson TK. Fibrinolysis and von Willebrand factor in Alzheimer's disease and vascular dementia - a case-referent study. Thromb Res. 2009 Oct 28.

Remmets J, Boman K, Olofsson M. How many systolic and diastolic echocardiographic variables do we have do measure? - an exploratory study in elderly patients. European Journal of Heart Failure, submitted. 2009.

Stenlund H, Lonnberg G, Jenkins P, Norberg M, Persson M, Messner T, Boman K, Pearson T, Wall S, Nystrom L, Weinehall L. Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population. Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):321-4.

Kristofferzon ML, Johansson I, Brännström M, Arenhall E, Baigi A Brunt D, Fridlund B, Nilsson U, Persson S, Rask M, Wieslander I, Ivarsson B and the SAMMI-study group. Validity and reliability testing of the Watts Sexual Function Questionnaire (WSFQ) in a Swedish sample of persons with heart disease: a pilot study. European Journal of Cardiovascular Nursing. European Journal of Cardiovascular Nursing, in press, corrected proof. doi:10.1016/j.ejcnurse.2009.12.004. Available online 13 January 2010.

Hernestål Boman J, Jansson J-H, Nilsson TK, Eliasson M, Johansson L.Long-term stability of fibrinolytic factors stored at -80°C. Thrombosis Research Accepted 2009.

Boman K, Gerdts E, Wachtell K, Dahlof B, Nieminen MS, Olofsson M, Papademetriou V, Devereux RB. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):242-8.

Chinali M, Aurigemma GP, de Simone G, Mishra RK, Gerdts E, Wachtell K, Boman K, Dahlof B, Devereux RB. Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy). Am J Cardiol. 2009 Oct 15;104(8):1098-104.

Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Barwolf C, Kesaniemi VA, Malbecq W, Rossebo AB, Wachtell K, Willenheimer R, Pedersen TR. Observed and predicted reduction of ischaemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial. Eur Heart J submitted. 2009.

Wennberg P, Wensley F, Johansson L, Boman K, Angelantonio ED, Rumley A, Lowe G, Hallmans G, Jansson JH. Reduced risk of myocardial infarction related to active commuting: inflammatory and haemostatic effects are potential major mediating mechanisms. Eur J Cardiovasc Prev Rehabil. 2009 Oct 8.

Lofgren C, Boman K, Olofsson M, Lindholm L. Is cardiac consultation with remote-controlled real-time echocardiography a wise use of resources? Telemed J E Health. 2009 Jun;15(5):431-8.

Brannstrom M, Bjorck M, Strandberg G, Wanhainen A. Patients' experiences of being informed about having an abdominal aortic aneurysm - a follow-up case study five years after screening. J Vasc Nurs. 2009 Sep;27(3):70-4.

Lundman B, Brannstrom M, Hagglund L, Strandberg G. Fatigue in elderly with chronic heart failure: an under-recognized symptom. Aging Health. 2009;5(5):619-24.

Fhärm E, Rolandsson O, Svensson M, Boman K. Is there an appropriate focus on coronary heart disease in patients with newly diagnosed type 2 diabetes? Diabetic medicin (DME-2009-00613).

Boman K, Hernestal Boman J, Andersson J, Olofsson M, Dahlof B. Effects on atenolol or losartan on fibrinolysis and von Willebrand factor in hypertensive patients with left ventricular hypertrophy. Clinical and Applied Thrombosis/Hemostasis. 2009.

Boman K, Jansson JH, Nilsson T, Swedberg K, Cleland JG, Poole-Wilson P. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure - a COMET substudy. Thromb Res. 2009 Sep 15.

Olofsson M, Boman K. Usefulness of natriuretic peptides in primary health care - an explorative study in elderly patients. Scand J Prim Care Submitted. 2009

Thogersen AM, Nilsson TK, Weinehall L, Boman K, Eliasson M, Hallmans G, Jansson JH. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years. Blood Coagul Fibrinolysis. 2009 Jul;20(5):340-6.

Nilsson LM, Wennberg M, Lindahl B, Eliasson M, Jansson JH, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of first acute myocardial infarction; a nested case/referent study. Nutr Metab Cardiovasc Dis. 2009 Aug 18.

Lindahl B, Nilsson T, Borch-Johnsen K, Roder ME, Soderberg S, Widman L, Johnson O, Hallmans G, Jansson JH. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: Pronounced short-term impact but long-term adherence problems. Scand J Public Health. 2009 Jan 30.

Lind M, Boman K, Johansson L, Nilsson TK, Ohlin AK, Birgander LS, Jansson JH. Thrombomodulin as a marker for bleeding complications during warfarin treatment. Arch Intern Med. 2009 Jul 13;169(13):1210-5.

Gronlund H, Hallmans G, Jansson JH, Boman K, Wikstrom M, de Faire U, et al. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden. Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):382-6.

Andersson J, Johansson L, Ladenvall P, Wiklund PG, Stegmayr B, Jern C, et al. C-Reactive Protein Is a Determinant of First-Ever Stroke: Prospective Nested Case-Referent Study. Cerebrovasc Dis. 2009 Apr 24;27(6):544-51.

Boman K, Olofsson M, Forsberg J, Boström SÅ. Remote-controlled robotic arm for real-time echocardiography: the diagnostic future for patients in rural areas. Telemedicine and e-Health. 2009;15(2):1-6.

Sahli D, Eriksson JW, Boman K, Svensson MK. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes. Thrombosis Research. 2009;123:701-6.

van Guelpen B, Hultdin J, Johansson I, Witthöft C, Weinehall L, Eliasson M, Jansson JH et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. JIM-08-0463R2. 2009.

Forsberg KA, Björkman T, Sandman PO, Sandlund M. Physical health - a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and theri staff. Nord J Psychiatry. 2008;62(6):486-95.

Andersson J, Boman K, Jansson JH, Nilsson TK, Lindahl B. Effect of intensive lifestyle intervention on C-reactive protein in subjects with impaired glucose tolerance and obesity. Results from a randomized controlled trial with 5-year follow-up. Biomarkers. 2008 Nov;13(7):671-9.

Hagglund L, Boman K, Lundman B. The experience of fatigue among elderly women with chronic heart failure. Eur J Cardiovasc Nurs. 2008 Feb 8.

Hagglund L, Boman K, Lundman B, Brulin C. Depression among elderly people with and without heart failure, managed in a primary healthcare setting. Scand J Caring Sci. 2008 Sep;22(3):376-82.

Hägglund L, Boman K., Stenlund, H., Lundman, B., & Brulin, C. (2008). Factors related to fatigue among older patients with heart failure in primary health care. International Journal of Older People Nursing, 3(2), 96-103.

Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep 25;359(13):1343-56.

Sahli D, Eriksson JW, Boman K, Svensson MK. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes. Thromb Res. 2008 Oct 20.

Boman K. [High mortality among myocardial infarction patients not treated in coronary care units. A deeper analysis is necessary]. Lakartidningen. 2008 Apr 23-May 6;105(17-18):1270-1.

Gronlund H, Hallmans G, Jansson JH, Wikström M, de Faire U, Frostegard J. Low levels of IgM antibodies against phosphorylcholine predict development of coronary artery disease in a pupulation based cohort from Northern Sweden. Eur J Cardiovasc Prev Rehabil (HJR200518) Accepted. 2008.

Lindahl B, Nilsson T, Borch-Johnsen K, Roder M, Soderberg S, Widman L, Jansson JH et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance. Pronounced short-term impact but long-term adherence problems. Scandinavian Journal of Public Health. 2008 Submitted.

Chinali M, De Simone G, Wachtell K, Gerdts E, Gardin JM, Boman K, et al. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Hypertension. 2008.

Cicala S, de Simone G, Wachtell K, Gerdts E, Boman K, Nieminen MS, et al. Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens. 2008 Apr;26(4):806-12.

Eriksson M, Johnson O, Boman K, Hallmans G, Hellsten G, Nilsson TK, et al. Improved fibrinolytic activity during exercise may be an effect of the adipocyte-derived hormones leptin and adiponectin. Thromb Res. 2008;122(5):701-8.

Eriksson MA, Rask E, Johnson O, Carlstrom K, Ahren B, Eliasson M, Boman K et al. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis. Blood Coagul Fibrinolysis. 2008 Oct;19(7):625-32.

Gerdts E, Okin P, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment. The Losartan Intervention For Endpoint reduction in hypertension study. Hypertension. 2008;51:TBD (E-pub 8 February 2008).

Norberg EB, Boman K, Lofgren B. Activities of daily living for old persons in primary health care with chronic heart failure. Scand J Caring Sci. 2008 Jun;22(2):203-10.

Sjalander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. J Intern Med. 2008 Jan;263(1):52-60.

Lundblad D, Holmgren L, Jansson JH, Naslund U, Eliasson M. Gender differences in trends of acute myocardial infarction events: The Northern Sweden MONICA study 1985 - 2004. BMC Cardiovasc Disord. 2008 Jul 25;8(1):17.

Wennberg M, Bergdahl IA, Stegmayr B, Hallmans G, Lundh T, Skerfving S, et al. Fish intake, mercury, long-chain n-3 polyunsaturated fatty acids and risk of stroke in northern Sweden. Br J Nutr. 2007 May 31:1-8.

Wanhainen A, Nilsson TK, Bergqvist D, Boman K, Bjorck M. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg. 2007 Jun;45(6):1109-13.

Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A primary health care center study. Cardiology. 2007;107(4):226-32.

Hagglund L, Boman K, Olofsson M, Brulin C. Fatigue and health-related quality of life in elderly patients with and without heart failure in primary healthcare. Eur J Cardiovasc Nurs. 2007 Sep;6(3):208-15.

Sjalander A, Jansson JH, Bergqvist D, Eriksson H, Svensson P. [Evidence for thrombosis prophylaxis to high-risk patients]. Lakartidningen. 2007 May 14-29;104(20-21):1585-7.

Burström M, Boman K, Strandberg G, Brulin C. Manliga patienter med hjärtsvikt och deras erfarenhet av att vara trygga och otrygga. Vård i Norden 3 Publ No 85. 2007;27(No.3):24-8.

Ekblom K, Hultdin J, Stegmayr B, Johansson I, Van Guelpen B, Hallmans G, Johansson L et al. Iron Stores and HFE Genotypes Are Not Related to Increased Risk of Ischemic Stroke. A Prospective Nested Case-Referent Study. Cerebrovasc Dis. 2007 Sep 18;24(5):405-11.

Själander A, Jansson J, Bergqvist D, Eriksson H, Carlberg B, Svensson P. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolim in acutely ill medical in-patients - a meta-analysis. JIM accepterad. 2007;0338.R2.

Wallvik J, Sjalander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007 Jun;25(2):123-8.

Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson J. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 2007 Sep;262(3):360-7.

Wanhainen A, Nilsson TK, Bergqvist D, Boman K, Bjorck M. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg. 2007 Jun;45(6):1109-13.

Rossebo AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, et al. Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study. Am J Cardiol. 2007 Apr 1;99(7):970-3.

Rantapaa-Dahlqvist S, Boman K, Tarkowski A, Hallmans G. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis. 2007 Jan;66(1):121-3.

Palmieri V, Okin PM, Simone GD, Bella JN, Wachtell K, Gerdts E, Boman K et al. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. J Hypertens. 2007 May;25(5):1079-85.

Märta Skoglund, Kurt Boman, Claes Lundgren och Jan-Erik Ögren. ”Den äldre människan är inte alltid ”vuxen”. Debattartikel i Läkartidningen nr XX 2007 volym 104.

Nilsson JB, Jansson J, Boman K, Nilsson T, Näslund U. The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with Streptokinase. Journal of Thromb and Thrombolysis 2007 aug 25.

Cicala S, Devereux RB, de Simone G, Wachtell K, Gerdts E, Boman K, et al. Electrocardiographic and Echocardiographic Detection of Myocardial Infarction in Patients with Left-Ventricular Hypertrophy The LIFE Study. Am J Hypertens. 2007 Jul;20(7):771-6.

Brannstrom M, Ekman I, Boman K, Strandberg G. Being a close relative of a person with severe, chronic heart failure in palliative advanced home care - a comfort but also a strain. Scand J Caring Sci. 2007 Sep;21(3):338-44.

Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007 Feb;49(2):311-6.

Trichopoulou A, Bamia C, Norat T, Overvad K, Schmidt EB, Tjonneland A et al. Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study. Eur J Epidemiol. 2007 Oct 10.

Wennberg P, Lindahl B, Hallmans G, Messner T, Weinehall L, Johansson L, et al. The effects of commuting activity and occupational and leisure time physical activity on risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):924-30.

Claesson M, Birgander LS, Jansson JH, Lindahl B, Burell G, Asplund K, et al. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial. J Intern Med. 2006 Oct;260(4):320-31.

Lind M, Jansson JH. [Deep venous thrombosis]. Läkartidningen. 2006;Mar 29-Apr 4;103(13):1031-4.

Ekstedt B, Jansson JH, Boman K. Inga vetenskapliga skäl längre för B-vitaminer till hjärt-kärlsjuka. Läkartidningen. 2006;103:3464-6.

Wennberg M, Lundh T, Bergdahl IA, Hallmans G, Jansson JH, Stegmayr B, et al. Time trends in burdens of cadmium, lead, and mercury in the population of northern Sweden. Environ Res. 2006 Mar;100(3):330-8.

Eliasson M, Janlert U, Jansson JH, Stegmayr B. Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med. 2006;260:551-9.

Boman K. Riskstratifiering vid hjärtsvikt. Information från Läkemedelsverket. 2006;17(1):35-7.

Forssell A, Boman K. Erfarenheter av palliativ avancerad hemsjukvård för patienter med svår kronisk hjärtsvikt. Vård i Norden 3. 2006;26(No. 3 ):44-8.

Brannstrom M, Ekman I, Norberg A, Boman K, Strandberg G. Living with severe chronic heart failure in palliative advanced home care. Eur J Cardiovasc Nurs. 2006 Dec;5(4):295-302.

Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, et al. Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study. Hypertension. 2006 May;47(5):868-73.

Olofsson M, Edebro D, Boman K. Are Elderly Patients with Suspected HF Misdiagnosed? A Primary Health Care Center Study. Cardiology. 2006 Sep 1;107(4):226-32.

Jernberg T, Boman K, James S, Lindahl B, Stridsberg M, Swedberg K, et al. [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]. Lakartidningen. 2006 Apr 26-May 2;103(17):1289-92, 95.

Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K et al. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens. 2006 Oct;24(10):2079-84.

Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scand J Public Health. 2006;34(6):576-83.

Ekman I, Andersson G, Boman K, Charlesworth A, Cleland JG, Poole-Wilson P, et al. Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Educ Couns 2006 jun;61(3):348-53.

Jansson JH. [Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now]. Lakartidningen. 2005 Jun 27-Jul 10;102(26-27):1984-5.

Boman K, Olofsson M, Dahlof B, Gerdts E, Nieminen MS, Papademetriou V, et al. Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study). Am J Cardiol 2005;95(2):280-3.

Ekman I, Boman K, Olofsson M, Swedberg K. Gender makes a difference in the description of dyspnoea in patients with chronic heart failure. European Journal of Cardiovascular Nursing. Eur J Cardiovasc Nurs 2005 Jun;4(2):117-21.

Brannstrom M, Brulin C, Norberg A, Boman K, Strandberg G. Being a palliative nurse for persons with severe congestive heart failure in advanced homecare. Eur J Cardiovasc Nurs. 2005 Jun 7;4(4):314-23.

Nilsson TK, Boman K, Jansson JH, Thogersen AM, Berggren M, Broberg A, et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years. Thromb Res 2005;116(3):249-54.

Oldgren J, Fellenius C, Boman K, Jansson JH, Nilsson TK, Wallentin L, et al. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease. J Intern Med 2005;258(5):420-7.

Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegård J, Björck M. Risk factors associated with abdominal aortic aneurysm: A population-based study with historical and current data. J Vasc Surg 2005;41:390-6.

Wiklund PG, L. Nilsson, SN. Ardnor, P. Eriksson, L. Johansson, B. Stegmayr, A. Hamsten, D. Holmberg, K. Asplund. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 2005;36(8):1661-5.

Wiklund PG, L. Johansson, P. Ladenvall, A. Tjärnlund, B. Stegmayr, C. Jern. Tissue-type plasminogen activator -7,351C>T polymorphism does not influence the risk of stroke. A prospective case-referent study. Submitted 2005.

Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004;110(11):1456-62.

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292(19):2350-6.

Hultdin J, Thogersen AM, Jansson JH, Nilsson TK, Weinehall L, Hallmans G. Elevated plasma homocysteine: cause or consequence of myocardial infarction? J Intern Med 2004;256(6):491-8.

Johansson L, Jansson JH, Stegmayr B, Nilsson TK, Hallmans G, Boman K. Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case-referent study. Stroke 2004;35(4):826-30.

Kontos J, Papademetriou V, Wachtell K, Palmieri V, Liu JE, Gerdts E, Boman K, Nieminen M. S, Dahlof B, Devereux R. B. Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens 2004;18(6):431-6.

Olsen MH, Wachtell K, Bella JN, Liu JE, Boman K, Gerdts E, et al. Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). Am J Cardiol 2004;94(8):1076-80.

Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 2004;256(2):128-36.

Thogersen AM, Soderberg S, Jansson JH, Dahlen G, Boman K, Nilsson TK, et al. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004;11(1):33-40.

Warensjo E, Jansson JH, Berglund L, Boman K, Ahren B, Weinehall L, et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br J Nutr 2004;91(4):635-42.

Cline C, Boman K, Swedberg K. [A study of primary health care in 15 different countries. Examination and treatment of patients with heart failure should be better]. Lakartidningen 2003;100(14):1242-3.

Forsberg KA, Olofsson CG. Experiences with telemedicine in psychiatric care in the county of Vasterbotten. A practical working tool which is used more and more. Lakartidningen. 2003 Dec 18;100(51-52):4287-8.

Devereux RB, Wachtell K, Gerdts E, Aurup P, Boman K, Edelman J, et al. Association of left ventricular hypertrophy regression and heart rate reduction with determinants of myocardial oxygen consumption and cardiovascular events: The LIFE study. J Am Coll Cardiol 2003;41(6 Suppl B):400.

Olsen MH, Wachtell K, Bella JN, Boman K, Gerdts E, Papademetriou V, et al. The effect of losartan versus atenolol on aortic valve sclerosis: A LIFE study. J Am Coll Cardiol 2003;41(6 Suppl B):505-6.

Eliasson. M.C., J.H. Jansson, B. Lindahl, B. Stegmayr. High levels of tPA antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovascular Diabetology, 2003. 2(1): p. 19.

Hallmans. G., A. Agren, G. Johansson, A. Johansson, B. Stegmayr, J.H. Jansson, B. Lindahl, O. Rolandsson, S. Soderberg, M. Nilsson, I. Johansson, L. Weinehall. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scandinavian Journal of Public Health, 2003. Suppl 61: p. 18-24.

Jansson JH, Boman K, Messner T. Trends in blood pressure, lipids, lipoproteins and glucose metabolism in the Northern Sweden MONICA project 1986-99. Scand J Public Health 2003;Suppl 61:43-50.

Aurigemma GP, Devereux RB, Wachtell K, Palmieri V, Boman K, Gerdts E, et al. Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment. Am J Hypertens 2003;16(3):180-6.

Aurigemma GP, Devereux RB, Wachtell K, Palmieri V, Boman K, Gerdts E, et al. Should previously treated hypertensive patients with left ventricular hypertrophy be enrolled in clinical trials of LV mass regression? The LIFE study. 2002.

Bella JN, Wachtell K, Boman K, Palmieri V, Papademetriou V, Gerdts E, et al. Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Am J Cardiol 2002;89(3):337-41.

Boman KO, Jansson JH, Nyhlen KA, Nilsson TK. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction. Thromb Haemost 2002;87(2):311-6.

Cline CM, Boman K, Holst M, Erhardt LR, Failure f SS. The management of heart failure in Sweden. Eur J Heart Fail 2002;4(3):373-6.

Devereux RB, Palmieri V, Liu JE, Wachtell K, Bella JN, Boman K, et al. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study. J Hypertens 2002;20(7):1445-50.

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension: the LIFE study. 2002.

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Left ventricular mass change during treatment and outcome in hypertensive patients with left ventricular hypertension: the LIFE Trial. J Hypertens; in press 2002.

Gerdts E, Papademetriou V, Palmieri V, Boman K, Bjornstad H, Wachtell K, et al. Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 2002;89(4):399-402.

Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002;39(3):739-43.

Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke. Thromb Haemost 2002;87(2):211-7.

Johansson L, Ladenvall P, Wiklund PG, Tjarnlund A, Jansson JH, Stegmayr B, et al. Tissue-type plasminogen activator -7,351 C/T enhancer polymorphism and risk of first-ever stroke. Dissertation, Umeå University 2002.

Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, Tjarnlund A, et al. Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost 2002;87(1):105-9.

Nilsson. J.B., T.K. Nilsson, J.H. Jansson, K. Boman, S. Soderberg, U. Naslund. The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction. Journal of Internal Medicine, 2002. 252(5): p. 405-11.

Nilsson TK, Spence JD, Nilsson PM, Eliasson M, Jansson JH, Boman K. Quantitative measurement of carotid atherosclerosis in relation to levels of von Willebrand factor and fibrinolytic cariables in plasma - a 2 year follow-up study. Journal of Cardiovascular Risk 2002;9:1-7.

Wachtell K, Dahlof B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella J. N, Devereux R. B. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J 2002;144(6):1057-64.

Weinehall L, Ohgren B, Persson M, Stegmayr B, Boman K, Hallmans G, et al. High remaining risk in poorly treated hypertension: the 'rule of halves' still exists. J Hypertens 2002;20(10):2081-8.

Welch. A.A., E. Lund, P. Amiano, M. Dorronsoro, M. Brustad, M. Kumle, M. Rodriguez, C. Lasheras, L. Janzon, J. Jansson et al. Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutrition, 2002. 5(6B): p. 1273-85.

Devereux RB, Bella J, Boman K, Gerdts E, Nieminen MS, Rokkedal J, et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Blood Press 2001;10(2):74-82.

Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, Schutz A, et al. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 2001;86(3):397-404.

Johansson A, Boman K, Cederquist K, Forsberg H, Olsson T. Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy. J Intern Med 2001;249(6):503-10.

Thogersen AM, Nilsson TK, Dahlen G, Jansson JH, Boman K, Huhtasaari F, et al. Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coron Artery Dis 2001;12(2):85-90.

Thogersen AM, Nilsson TK, Dahlen G, Jansson JH, Boman K, Huhtasaari F, et al. Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coron Artery Dis 2001;12(2):85-90.

Wanhainen A, Bjorck M, Boman K, Rutegard J, Bergqvist D. Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm. J Vasc Surg 2001;34(2):229-35.

Weinehall L, Hellsten G, Boman K, Hallmans G, Asplund K, Wall SW. Can a sustainable community intervention reduce the health gap?--10- Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease. Scand J Public Health 2001;Suppl(56):59-68.

Weinehall L, Hellsten G, Boman K, Hallmans G. Prevention of cardiovascular disease in sweden: the Norsjo community intervention programme, motives, methods and intervention components. Scand J Public Health 2001;Suppl(56):13-20.

Stöd vår forskning redan idag

Så hjälper du till

Stiftelsen vill inspirera och stödja yngre men även äldre läkare, sjuksköterskor, apotekare med flera till att forska inom områdena medicin och omvårdnad inom Skellefteå sjukvård (kommunerna Skellefteå och Norsjö).

Postgiro & Bankgiro

Stöd vår verksamhet genom att sätta in pengar på följande Post- och Bankgiro:

Stiftelsens postgiro 444 81 29-9
Stiftelsens bankgiro 710-9721
Stiftelsens swish 1233351574

Dela vår hemsida

Hjälp vår stiftelse och våra forskare genom att sprida vår sida vidare via sociala medier.
Information om cookies